Carlsmed (CARL) Return on Capital Employed (2025 - 2026)

Carlsmed (CARL) reported Return on Capital Employed of 29.75% for Q1 2026, down 15.02% quarter-over-quarter from 25.86% in Q4 2025.

Carlsmed (CARL) Return on Capital Employed (2025 - 2026) Analysis & Trends

Carlsmed has reported Return on Capital Employed for 2 years, with the latest figure at 29.75% in Q1 2026.

For the quarter ending Q1 2026, Return on Capital Employed changed N/A year-over-year to 29.75%; the trailing twelve-month figure through Mar 2026 stood at 29.75% (changed N/A YoY), and the FY2025 full-year result was 39.87%, changed N/A from the prior year.
Return on Capital Employed for Q1 2026 stood at 29.75%, down from 25.86% in the prior quarter.
The five-year high for Return on Capital Employed was 25.86% in Q4 2025, with the low at 31.22% in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn	13.00%
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn	2.09%
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn	10.67%
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn	-163.65%
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn	-4.23%
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn	21.81%
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn	4.73%
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn	4.60%
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn	2.23%
10	Carlsmed	265.54 Mn	168.34 Mn	12.43 Mn	-29.75%

Download Data